Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Men’s perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia

Authors: Maggie Kirkman, Kate Young, Susan Evans, Jeremy Millar, Jane Fisher, Danielle Mazza, Rasa Ruseckaite

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

The Victorian Prostate Cancer Registry (Australia) revealed poorer rates of survival for men diagnosed with prostate cancer in one Victorian regional area than for men in metropolitan Melbourne. We sought to explore the perceptions and experiences of prostate cancer diagnosis, treatment, and care of men diagnosed with prostate cancer who lived in regional or metropolitan areas and of men who had not been so diagnosed. Our goal was to contribute to the evidence from which can be built continuing improvements in prostate health care.

Methods

Using the qualitative method of in-depth interviews to gain access to explanation and meaning, we interviewed 21 men: 10 recruited through the Prostate Cancer Outcome Registry-Victoria and 11 from the community. Transcripts were analysed thematically.

Results

We identified four main themes within which men discussed prostate cancer: Case-finding, Diagnosis, Treatment and Care, and Spreading the Word. Contrasts revealed between regional and metropolitan areas related mostly to the more limited supportive care in regional areas.

Conclusions

It is evident from the perspectives of these men that every aspect of prostate cancer care would benefit from attention: publicising the need to check prostate health, treatment, and supporting men in the years after treatment. Continuing to work on systemic improvements is an important goal for all those committed to men’s health.
Appendix
Available only for authorised users
Literature
1.
go back to reference Evans SM, Millar JL, Davis ID, Murphy DG, Bolton DM, Giles GG, Frydenberg M, Andrianopoulos N, Wood JM, Frauman AG. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. Med J Aust. 2013;198:540–5.CrossRefPubMed Evans SM, Millar JL, Davis ID, Murphy DG, Bolton DM, Giles GG, Frydenberg M, Andrianopoulos N, Wood JM, Frauman AG. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. Med J Aust. 2013;198:540–5.CrossRefPubMed
2.
go back to reference Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK. Urban-rural differences in prostate cancer outcomes in Australia: what has changed? Med J Aust. 2011;194:293–6.PubMed Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK. Urban-rural differences in prostate cancer outcomes in Australia: what has changed? Med J Aust. 2011;194:293–6.PubMed
4.
go back to reference Australian Bureau of Statistics. Australian statistical geography standard (ASGS): volume 4 - significant urban areas, urban Centres and localities (cat. No. 1270.0.55.004). Government of Australia: Canberra; 2011. Australian Bureau of Statistics. Australian statistical geography standard (ASGS): volume 4 - significant urban areas, urban Centres and localities (cat. No. 1270.0.55.004). Government of Australia: Canberra; 2011.
5.
go back to reference Obertová Z, Hodgson F, Scott-Jones J, Brown C, Lawrenson R. Rural-urban differences in prostate-specific antigen (PSA) screening and its outcomes in New Zealand. J Rural Health. 2016;32:56–62.CrossRefPubMed Obertová Z, Hodgson F, Scott-Jones J, Brown C, Lawrenson R. Rural-urban differences in prostate-specific antigen (PSA) screening and its outcomes in New Zealand. J Rural Health. 2016;32:56–62.CrossRefPubMed
6.
go back to reference Jemal A, Ward E, Wu X, Martin HJ, McLaughlin CC, Thun MJ. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidem Biomar. 2005;14:590–5.CrossRef Jemal A, Ward E, Wu X, Martin HJ, McLaughlin CC, Thun MJ. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidem Biomar. 2005;14:590–5.CrossRef
8.
go back to reference Evans SM, Millar JL, Wood JM, Davis ID, Bolton D, Giles GG, Frydenberg M, Frauman A, Costello A, McNeil JJ. The prostate cancer registry: monitoring patterns and quality of care for men diagnosed with prostate cancer. BJU Int. 2013;111:E158–66.CrossRefPubMed Evans SM, Millar JL, Wood JM, Davis ID, Bolton D, Giles GG, Frydenberg M, Frauman A, Costello A, McNeil JJ. The prostate cancer registry: monitoring patterns and quality of care for men diagnosed with prostate cancer. BJU Int. 2013;111:E158–66.CrossRefPubMed
9.
go back to reference Ruseckaite R, Sampurno F, Millar J, Frydenberg M, Evans S. Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia. BMC Urol. 2016;16:54.CrossRefPubMedPubMedCentral Ruseckaite R, Sampurno F, Millar J, Frydenberg M, Evans S. Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia. BMC Urol. 2016;16:54.CrossRefPubMedPubMedCentral
10.
go back to reference Glaser AW, Fraser LK, Corner J, Feltbower R, Morris EJ, Hartwell G, Richards M. Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey. BMJ Open. 2013;3:e002317.CrossRefPubMedPubMedCentral Glaser AW, Fraser LK, Corner J, Feltbower R, Morris EJ, Hartwell G, Richards M. Patient-reported outcomes of cancer survivors in England 1–5 years after diagnosis: a cross-sectional survey. BMJ Open. 2013;3:e002317.CrossRefPubMedPubMedCentral
11.
go back to reference Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O’Connell DL, Armstrong BK. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.CrossRefPubMedPubMedCentral Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward J, O’Connell DL, Armstrong BK. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.CrossRefPubMedPubMedCentral
12.
go back to reference Christie DRH, Sharpley CF, Bitsika V. Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. Psycho-Oncologia. 2015;24:1002–11.CrossRef Christie DRH, Sharpley CF, Bitsika V. Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer. Psycho-Oncologia. 2015;24:1002–11.CrossRef
13.
go back to reference Hedestig O, Sandman P-O, Tomic R, Widmark A. Living after radical prostatectomy for localized prostate cancer. A qualitative analysis of patient narratives. Acta Oncol. 2005;44:679–86.CrossRefPubMed Hedestig O, Sandman P-O, Tomic R, Widmark A. Living after radical prostatectomy for localized prostate cancer. A qualitative analysis of patient narratives. Acta Oncol. 2005;44:679–86.CrossRefPubMed
14.
go back to reference Hyde MK, Newton RU, Galvão DA, Gardiner RA, Occhipinti S, Lowe A, Wittert GA, Chambers SK. Men’s help-seeking in the first year after diagnosis of localised prostate cancer. Eur J Cancer Care. 2017;26:e12497.CrossRef Hyde MK, Newton RU, Galvão DA, Gardiner RA, Occhipinti S, Lowe A, Wittert GA, Chambers SK. Men’s help-seeking in the first year after diagnosis of localised prostate cancer. Eur J Cancer Care. 2017;26:e12497.CrossRef
15.
go back to reference King AJL, Evans M, Moore THM, Paterson C, Sharp D, Persad R, Huntley AL. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men’s experiences and unmet needs. Eur J Cancer Care. 2015;24:618–34.CrossRef King AJL, Evans M, Moore THM, Paterson C, Sharp D, Persad R, Huntley AL. Prostate cancer and supportive care: a systematic review and qualitative synthesis of men’s experiences and unmet needs. Eur J Cancer Care. 2015;24:618–34.CrossRef
16.
go back to reference Cormie P, Oliffe JL, Wootten AC, Galvão DA, Newton RU, Chambers SK. Improving psychosocial health in men with prostate cancer through an intervention that reinforces masculine values – exercise. Psycho-Oncologia. 2015;25:232–5.CrossRef Cormie P, Oliffe JL, Wootten AC, Galvão DA, Newton RU, Chambers SK. Improving psychosocial health in men with prostate cancer through an intervention that reinforces masculine values – exercise. Psycho-Oncologia. 2015;25:232–5.CrossRef
17.
go back to reference Gray RE, Fitch M, Phillips C, Labrecque M, Fergus K. To tell or not to tell: patterns of disclosure among men with prostate cancer. Psycho-Oncologia. 2000;9:273–82.CrossRef Gray RE, Fitch M, Phillips C, Labrecque M, Fergus K. To tell or not to tell: patterns of disclosure among men with prostate cancer. Psycho-Oncologia. 2000;9:273–82.CrossRef
18.
go back to reference Gray RE, Fitch M, Phillips C, Labrecque M, Fergus K. Managing the impact of illness: the experiences of men with prostate cancer and their spouses. J Health Psychol. 2000;5:531–48.CrossRefPubMed Gray RE, Fitch M, Phillips C, Labrecque M, Fergus K. Managing the impact of illness: the experiences of men with prostate cancer and their spouses. J Health Psychol. 2000;5:531–48.CrossRefPubMed
19.
go back to reference O’Shaughnessy PK, Laws TA, Esterman AJ. The prostate cancer journey: results of an online survey of men and their partners. Cancer Nurs. 2015;38:E1–E12.CrossRefPubMed O’Shaughnessy PK, Laws TA, Esterman AJ. The prostate cancer journey: results of an online survey of men and their partners. Cancer Nurs. 2015;38:E1–E12.CrossRefPubMed
20.
go back to reference Hamilton LD, Van Dam D, Wassersug RJ. The perspective of prostate cancer patients and patients’ partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples. Psycho-Oncologia. 2016;25:823–31.CrossRef Hamilton LD, Van Dam D, Wassersug RJ. The perspective of prostate cancer patients and patients’ partners on the psychological burden of androgen deprivation and the dyadic adjustment of prostate cancer couples. Psycho-Oncologia. 2016;25:823–31.CrossRef
24.
go back to reference Crowe J, Wootten AC, Howard N. Prostate cancer testing: a snapshot of the attitudes and practice of Australian general practitioners. Aust J Prim Health. 2015;21:111–4.CrossRefPubMed Crowe J, Wootten AC, Howard N. Prostate cancer testing: a snapshot of the attitudes and practice of Australian general practitioners. Aust J Prim Health. 2015;21:111–4.CrossRefPubMed
25.
go back to reference Ruseckaite R, Evans S, Millar J, Holton S, Fisher J, Mazza D, Kirkman M. Prostate cancer diagnosis and care in regional areas: insights from qualitative interviews with GPs in Victoria, Australia. Qualitative Report. 2016;21:2365–79. Ruseckaite R, Evans S, Millar J, Holton S, Fisher J, Mazza D, Kirkman M. Prostate cancer diagnosis and care in regional areas: insights from qualitative interviews with GPs in Victoria, Australia. Qualitative Report. 2016;21:2365–79.
26.
go back to reference Hammarberg K, Kirkman M, de Lacey S. Qualitative research methods: when to use them and how to judge them. Hum Reprod. 2016;31:498–501.CrossRefPubMed Hammarberg K, Kirkman M, de Lacey S. Qualitative research methods: when to use them and how to judge them. Hum Reprod. 2016;31:498–501.CrossRefPubMed
27.
go back to reference Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.CrossRef
28.
go back to reference NVivo. NVivo qualitative data analysis software. In: Version 10: QSR international Pty ltd; 2012. NVivo. NVivo qualitative data analysis software. In: Version 10: QSR international Pty ltd; 2012.
29.
go back to reference Bowen DJ, Hannon PA, Harris JR, Martin DP. Prostate cancer screening and informed decision-making: provider and patient perspectives. Prostate Cancer PD. 2011;14:155–61.CrossRef Bowen DJ, Hannon PA, Harris JR, Martin DP. Prostate cancer screening and informed decision-making: provider and patient perspectives. Prostate Cancer PD. 2011;14:155–61.CrossRef
30.
go back to reference Jessen K, Søndergaard J, Larsen PV, Thomsen JL: Danish general practitioners’ use of prostate-specific antigen in opportunistic screening for prostate cancer: A survey comprising 174 GPs. Int J Fam Med. 2013;article ID 540707. Jessen K, Søndergaard J, Larsen PV, Thomsen JL: Danish general practitioners’ use of prostate-specific antigen in opportunistic screening for prostate cancer: A survey comprising 174 GPs. Int J Fam Med. 2013;article ID 540707.
33.
go back to reference Ford S, Scholz B, VN L. Social shedding: identification and health of men’s sheds users. Health Psychol. 2015;34:775–8.CrossRefPubMed Ford S, Scholz B, VN L. Social shedding: identification and health of men’s sheds users. Health Psychol. 2015;34:775–8.CrossRefPubMed
34.
go back to reference Gough B. Try to be healthy, but don't forgo your masculinity: deconstructing men’s health discourse in the media. Soc Sci Med. 2006;63:2476–88.CrossRefPubMed Gough B. Try to be healthy, but don't forgo your masculinity: deconstructing men’s health discourse in the media. Soc Sci Med. 2006;63:2476–88.CrossRefPubMed
35.
go back to reference Oliffe J. Health behaviors, prostate cancer, and masculinities. Men Masc. 2009;11:346–66.CrossRef Oliffe J. Health behaviors, prostate cancer, and masculinities. Men Masc. 2009;11:346–66.CrossRef
36.
go back to reference Wall DP, Kristjanson LJ, Fisher C, Boldy D, Kendall GE. Responding to a diagnosis of localized prostate cancer: Men’s experiences of normal distress during the first 3 postdiagnostic months. Cancer Nurs. 2013;36:E44–50.CrossRefPubMed Wall DP, Kristjanson LJ, Fisher C, Boldy D, Kendall GE. Responding to a diagnosis of localized prostate cancer: Men’s experiences of normal distress during the first 3 postdiagnostic months. Cancer Nurs. 2013;36:E44–50.CrossRefPubMed
37.
go back to reference Crangle CJ, Latini DM, Hart TL. The effects of attachment and outness on illness adjustment among gay men with prostate cancer. Psycho-Oncologia. 2017;26:500–7.CrossRef Crangle CJ, Latini DM, Hart TL. The effects of attachment and outness on illness adjustment among gay men with prostate cancer. Psycho-Oncologia. 2017;26:500–7.CrossRef
38.
go back to reference Rüesch P, Schaffert R, Fischer S, Feldman-Stewart D, Ruszat R, Spörri P, Zurkirchen M, Schmid H-P. Information needs of early-stage prostate cancer patients: within- and between-group agreement of patients and health professionals. Support Care Cancer. 2014;22:999–1007.CrossRefPubMed Rüesch P, Schaffert R, Fischer S, Feldman-Stewart D, Ruszat R, Spörri P, Zurkirchen M, Schmid H-P. Information needs of early-stage prostate cancer patients: within- and between-group agreement of patients and health professionals. Support Care Cancer. 2014;22:999–1007.CrossRefPubMed
39.
go back to reference Carter S, Garside P, Black A. Multidisciplinary team working, clinical networks, and chambers; opportunities to work differently in the NHS. Qual Saf Health Care. 2003;12:i25–8.CrossRefPubMedPubMedCentral Carter S, Garside P, Black A. Multidisciplinary team working, clinical networks, and chambers; opportunities to work differently in the NHS. Qual Saf Health Care. 2003;12:i25–8.CrossRefPubMedPubMedCentral
Metadata
Title
Men’s perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia
Authors
Maggie Kirkman
Kate Young
Susan Evans
Jeremy Millar
Jane Fisher
Danielle Mazza
Rasa Ruseckaite
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3699-1

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine